GlassScriptPhysician profile
David Randall Wilson
NPI 1982795761
$933.32
in general payments reported to CMS, 2019-2025
21 companies · $77.28 in 2025
The $77.28 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $214 · 2021: $31.25 · 2022: $42.48 · 2023: $36.98 · 2025: $77.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $284.16 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.83 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $66.47 | 2019-2022 | |
| Pharming Healthcare, INC. | $56.84 | 2019 | |
| Csl Behring | $52.69 | 2019 | |
| Irhythm Technologies, INC. | $50.64 | 2022-2023 | Zio Xt Patch |
| Shire North American Group INC | $43.55 | 2019 | |
| Novo Nordisk INC | $42.00 | 2019 | |
| Amarin Pharma, INC. | $30.67 | 2019 | |
| Pfizer INC. | $22.83 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.21 | 2025 | |
| Amgen INC. | $20.16 | 2019 | |
| Lilly USA, LLC | $19.67 | 2025 | Mounjaro |
| Vertex Pharmaceuticals Incorporated | $19.30 | 2025 | |
| Abbvie INC. | $18.13 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.10 | 2025 | The Cologuard Plus Collection Kit |
| Allergan, INC. | $17.56 | 2019 | |
| Adlon Therapeutics L.P. | $17.46 | 2019 | |
| Sunovion Pharmaceuticals INC. | $16.49 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.